Do you treat tumefactive multiple sclerosis differently than other forms of MS both in the acute and maintenance phase?

In general, I opt for early use of high-efficacy therapy like B-cell depletion. This is especially true if the patient has high levels of disease activity (recent relapses, enhancing lesions on MRI, and tumefactive lesions). A single lesion measuring >2cm is considered tumefactive.